TODAY'S ASIA TECH: Intel, WuXi Bio, iFlytek, Baidu
Jan.29,2024

Intel Corp. will work with Japanese telecom operator NTT to develop next-generation semiconductors, for which the Japanese government will provide a 45 billion yen subsidy, according to Nikkei.

Chinese pharmaceutical company WuXi Biologics (Cayman) Inc (2269.HK) earlier Monday denied allegations by U.S. lawmakers that its CEO Zhisheng Chen previously served in a military-affiliated institution.

iFLYHealth, the healthcare unit of Chinese artificial intelligence company iFlytek Co Ltd (002230.SZ), has applied for an initial public offering (IPO) in Hong Kong.

Taiwan-based panel maker Innolux Corp. reportedly won orders for power supply ICs from IDM giants NXP Semiconductors N.V. (NXP) and STMicroelectronics N.V. (ST).

Market rumours have spread that Innolux has now entered into cooperation with NXP and ST, and expected to trial production and gradually release production capacity in the second half of this year, Taiwan-based media Commercial Times reported on Monday.

The report pointed out that Innolux will start with Power IC products, which is different from the traditional professional packaging and testing foundry.

In response, an Innolux representative said it does not comment on market rumours or customers.

Samsung Electronics will integrate Chinese search engine giant Baidu Inc.'s (09888.HK) Ernie AI chatbot into its latest smartphone lineup, the Galaxy S24 series.

Chinese asset manager Harvest Fund Management became the first institution to apply for a spot bitcoin exchange-traded fund (ETF) in Hong Kong.

Harvest Global Investments Ltd. (HGI), Harvest Fund's Hong Kong-based asset management subsidiary, has filed an application for a spot bitcoin ETF with the Securities and Futures Commission of Hong Kong (SFC).

Related Topics

You must be login to post a comment.